N. Malamos

1.1k total citations
32 papers, 864 citations indexed

About

N. Malamos is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, N. Malamos has authored 32 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in N. Malamos's work include Cancer Treatment and Pharmacology (14 papers), Breast Cancer Treatment Studies (7 papers) and Ovarian cancer diagnosis and treatment (6 papers). N. Malamos is often cited by papers focused on Cancer Treatment and Pharmacology (14 papers), Breast Cancer Treatment Studies (7 papers) and Ovarian cancer diagnosis and treatment (6 papers). N. Malamos collaborates with scholars based in Greece, United States and Venezuela. N. Malamos's co-authors include D. Mavroudis, Ch. Kouroussis, V. Georgoulias, Ioannis G. Vlachonikolis, Aliki Stathopoulou, Stella Apostolaki, Maria Perraki, S. Kakolyris, N. Xenidis and Αthanasios Kotsakis and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

N. Malamos

32 papers receiving 832 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N. Malamos Greece	15	649	343	212	138	73	32	864
Rubina Qamar United States	12	479 0.7×	210 0.6×	239 1.1×	203 1.5×	83 1.1×	21	908
D F Hayes United States	8	464 0.7×	329 1.0×	152 0.7×	92 0.7×	110 1.5×	12	765
Chantal Bernard-Marty Belgium	14	845 1.3×	441 1.3×	247 1.2×	280 2.0×	191 2.6×	22	1.2k
Deanna McLeod Canada	15	461 0.7×	224 0.7×	229 1.1×	222 1.6×	52 0.7×	26	793
Tamer M. Fouad United States	19	683 1.1×	425 1.2×	291 1.4×	211 1.5×	101 1.4×	41	1.1k
Robert D. Legare United States	14	449 0.7×	230 0.7×	68 0.3×	150 1.1×	60 0.8×	35	822
Jenny Furlanetto Germany	16	553 0.9×	278 0.8×	215 1.0×	122 0.9×	66 0.9×	47	797
Marie-Josèphe Goudier France	9	883 1.4×	564 1.6×	185 0.9×	92 0.7×	35 0.5×	12	1.1k
Marzena Wełnicka-Jaśkiewicz Poland	17	610 0.9×	354 1.0×	154 0.7×	165 1.2×	48 0.7×	42	820
Yunfei Wang United States	16	413 0.6×	155 0.5×	186 0.9×	190 1.4×	50 0.7×	51	761

Countries citing papers authored by N. Malamos

Since Specialization

Citations

This map shows the geographic impact of N. Malamos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Malamos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Malamos more than expected).

Fields of papers citing papers by N. Malamos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Malamos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Malamos. The network helps show where N. Malamos may publish in the future.

Co-authorship network of co-authors of N. Malamos

This figure shows the co-authorship network connecting the top 25 collaborators of N. Malamos. A scholar is included among the top collaborators of N. Malamos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Malamos. N. Malamos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Malamos, N., et al.. (2019). CATALASE ACTIVITY, LIPID PEROXIDATION, AND PROTEIN CONCENTRATION IN LEAVES OF TOMATO INFECTED WITH MELOIDOGYNE JAVANICA. Nematropica. 48(1). 15–20. 7 indexed citations

Mavroudis, Dimitriοs, Alexios Matikas, N. Malamos, et al.. (2016). Dose-dense FEC followed by docetaxel versus docetaxel plus cyclophosphamide as adjuvant chemotherapy in women with HER2-negative, axillary lymph node-positive early breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG). Annals of Oncology. 27(10). 1873–1878. 24 indexed citations

Aravantinos, Gerasimos, et al.. (2013). Maintenance chemotherapy or not in ovarian cancer stages IIIA, B, C, and IV after disease recurrence.. PubMed. 17(4). 735–9. 7 indexed citations

Paparrigopoulos, Thomas, et al.. (2011). Depression, anxiety and general psychopathology in breast cancer patients: a cross-sectional control study.. PubMed. 24(5). 803–10. 53 indexed citations

Kosmas, Christos, N. Mylonakis, Georgios Tsakonas, et al.. (2009). Evaluation of the paclitaxel–ifosfamide–cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer. British Journal of Cancer. 101(7). 1059–1065. 24 indexed citations

Mavroudis, D., N. Malamos, Pavlos Papakotoulas, et al.. (2008). Randomized phase III trial comparing the sequential administration of docetaxel followed by epirubicin plus cyclophosphamide versus FE₇₅C as adjuvant chemotherapy in axillary lymph node-positive breast cancer. Journal of Clinical Oncology. 26(15_suppl). 521–521. 2 indexed citations

Kosmas, Christos, N. Tsavaris, N. Mylonakis, et al.. (2007). Docetaxel-Ifosfamide Combination in Patients with Advanced Breast Cancer Failing Prior Anthracycline- Based Regimens: Results of a Phase I-II Study. Journal of Chemotherapy. 19(3). 322–331. 3 indexed citations

Stathopoulos, George P., N. Malamos, Gerasimos Aravantinos, et al.. (2006). Weekly administration of topotecan–paclitaxel as second-line treatment in ovarian cancer. Cancer Chemotherapy and Pharmacology. 60(1). 123–128. 10 indexed citations

Stathopoulos, G., D. Tsavdaridis, N. Malamos, et al.. (2005). Irinotecan combined with docetaxel in pre-treated metastatic breast cancer patients: a phase II study. Cancer Chemotherapy and Pharmacology. 56(5). 487–491. 18 indexed citations

10.

Marangolo, M., et al.. (2005). Epoetin beta in patients with metastatic breast cancer receiving chemotherapy: Results from the Breast Cancer - Anemia and the Value of Erythropoietin (BRAVE) study. Journal of Clinical Oncology. 23(16_suppl). 8141–8141. 2 indexed citations

11.

Throuvalas, N., D. Antonadou, Robert S. Lavey, Mourad Boufi, & N. Malamos. (2004). Final results of a randomized phase II study evaluating the role of erythropoietin during radiochemotherapy for pelvic tumors. International Journal of Radiation Oncology*Biology*Physics. 60(1). S300–S300. 4 indexed citations

12.

Kosmas, Christos, et al.. (2003). Phase I–II study of docetaxel and ifosfamide combination in patients with anthracycline pretreated advanced breast cancer. British Journal of Cancer. 88(8). 1168–1174. 7 indexed citations

13.

Xenidis, Nikolaos, Ioannis G. Vlachonikolis, D. Mavroudis, et al.. (2003). Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer. Annals of Oncology. 14(6). 849–855. 88 indexed citations

14.

Antonadou, D., et al.. (2003). 926 Final results of a randomized phase II study evaluating the role of erythropoietin during radiochemotherapy for pelvic tumors. European Journal of Cancer Supplements. 1(5). S279–S279. 1 indexed citations

15.

Kosmas, Christos, Νicolas Tsavaris, Maria Vadiaka, et al.. (2001). Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens. European Journal of Cancer. 37(8). 972–978. 32 indexed citations

16.

Kouroussis, Ch., John Souglakos, Stylianos Kakolyris, et al.. (2001). Oxaliplatin in Combination with Infusional 5-Fluorouracil and Leucovorin Every 2 Weeks as First-Line Treatment in Patients with Advanced Colorectal Cancer: A Phase II Study. Oncology. 61(1). 36–41. 16 indexed citations

17.

Agelaki, Sofia, A. Alexopoulos, Charalambos Kouroussis, et al.. (2001). Salvage treatment with irinotecan and gemcitabine in breast cancer patients pretreated with taxanes and anthracyclines: a multicenter phase II study. European Journal of Cancer. 37. S197–S198. 1 indexed citations

18.

Kosmas, Christos, et al.. (2000). Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumours. British Journal of Cancer. 82(2). 300–307. 23 indexed citations

19.

Stathopoulos, G., S. Rigatos, & N. Malamos. (1999). Paclitaxel combined with cis-platin as second-line treatment in patients with advanced non-small cell lung cancers refractory to cis-platin.. Oncology Reports. 6(4). 797–800. 22 indexed citations

20.

Malamos, N., et al.. (1996). Pregnancy and Offspring after the Appearance of Breast Cancer. Oncology. 53(6). 471–475. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact